The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

Celestron’s CGEM DX 1400 is a 14-inch f/11 Schmidt-Cassegrain telescope on an equatorial CGEM DX mount. The kit includes NexStar control technology, Starbright XLT coatings, a stainless-steel tripod, ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

Fintel reports that on February 2, 2026, Guggenheim initiated coverage of Cullinan Therapeutics (NasdaqGS:CGEM) with a Buy recommendation. Analyst Price Forecast Suggests 160.41% Upside As of January ...

Most of us have heard the dictum "the trend is your friend." And this is undeniably the key to success when it comes to short-term investing or trading. But it isn't easy to ensure the sustainability ...

Cullinan Therapeutics’s Zipalertinib NDA has been accepted, making its February 27, 2027, PDUFA date their clearest near-term catalyst. Zipalertinib targets EGFR exon 20 insertion NSCLC, a niche but ...

Cullinan Therapeutics (CGEM) closed the last trading session at $8.28, gaining 5.9% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by ...

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.

CGEM's ability to cover its obligations with most liquid assets, excluding inventory is above that of its peers CGEM has a higher Return on Equity (-44.02%) than its peer average (-109.58%) ...